Ensysce Biosciences, Inc. (ENSC) Q4 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ensysce Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:02.770 Good morning and welcome to the Insights Biosciences, Inc. 00:00:02.770 -- 00:00:07.592 corporate update call. As a reminder, this conference is being recorded. 00:00:07.592 -- 00:00:11.953 Your hosts today are Dr. Lynn Kirkpatrick, Chief Executive Officer, Dr. 00:00:11.953 -- 00:00:17.015 Bill Smith, Chief Medical Officer, and Dave Humphrey, Chief Financial Officer. 00:00:17.015 -- 00:00:21.118 Before we begin the formal presentation, I would like to remind everyone that statements 00:00:21.118 -- 00:00:25.942 made on the call and webcast may include predictions, estimates, or other information 00:00:25.942 -- 00:00:30.266 that might be considered forward-looking. While these forward-looking statements represent 00:00:30.266 -- 00:00:34.870 our current judgment on what the future holds, they are subject to risks and uncertainties 00:00:34.870 -- 00:00:38.133 that could cause actual results to differ materially. 00:00:38.133 -- 00:00:42.217 You are cautioned not to place undue reliance on these forward-looking statements, which 00:00:42.217 -- 00:00:46.092 reflect our opinions only as of the date of this presentation. 00:00:46.092 -- 00:00:50.634 Please keep in mind that we are not obligating ourselves to revise or publicly release 00:00:50.634 -- 00:00:54.616 the results of any revision to these four looking statements in light of new information 00:00:54.616 -- 00:00:59.039 or future events. Throughout today's discussion, we will attempt to present some important 00:00:59.039 -- 00:01:03.000 factors relating to our business that may affect our predictions. 00:01:03.000 -- 00:01:08.043 You should also review our most recent forms 10Q and 10K for a more complete discussion 00:01:08.043 -- 00:01:12.512 of these factors and other ris...